Diego Martins

Dr. Diego Martins

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2021 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
PFPhilipe Oliveira Fernandes
Philipe Oliveira Fernandes
DMDiego Martins
Diego Martins
ABAline de Souza Bozzi
Aline de Souza Bozzi
JMJoão Paulo A. Martins
João Paulo A. Martins
AMAdolfo Henrique de Moraes
Adolfo Henrique de Moraes
VMVinicius Maltarollo
Vinicius Maltarollo

12 September 2024 in ChemBioChem
Verified
Journal Article
Closed access
DMDiego Martins
Diego Martins
PFPhilipe Oliveira Fernandes
Philipe Oliveira Fernandes
LVLucas A. Vieira
Lucas A. Vieira
VMVinicius Maltarollo
Vinicius Maltarollo
AMAdolfo Henrique Moraes
Adolfo Henrique Moraes

25 August 2020 in Revista Brasileira de Pesquisa em Educação em Ciências
Verified
Journal Article
Open access
PDF file
DMDiego Martins
Diego Martins
NMNilmara Braga Mozzer
Nilmara Braga Mozzer
TOThais Mara Anastácio Oliveira
Thais Mara Anastácio Oliveira
MCMelissa Soares Caetano
Melissa Soares Caetano
Neste trabalho, investigamos os papéis desempenhados pelos modelos computacionais e pelos processos de crítica e elaboração de analogias na compreensão conceitual do processo de interação fármaco-enzima. A investigação ocorreu com licenciandos do quinto período de um curso de Química ao vivenciarem um processo de ensino fundamentado na modelagem. As aulas foram filmadas e os materiais escritos produzidos pelos estudantes recolhidos. A análise desses materiais fundamentou a elaboração de um estudo de caso que nos permitiu evidenciar que a representação do sistema pelos modelos computacionais possibilitou que os estudantes desenvolvessem uma maior compreensão do conceito alvo, devido à visualização da disposição espacial dos átomos em macromoléculas e ao tratamento dinâmico desse tipo de sistema. Essa compreensão foi manifestada, principalmente, nos processos de crítica e criação de analogias. Por isso, realçamos a importância de que os licenciandos tenham experiências que os permitam refletir sobre as potencialidades e as limitações dos diferentes recursos de expressão de modelos ao vivenciarem processos de modelagem durante sua formação. Defendemos também a realização de novas investigações sobre a compreensão dos estudantes acerca da natureza dos modelos computacionais e das analogias nestes processos.

1 May 2026 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Open access
BSBrunno A. Salvatti
Brunno A. Salvatti
YLYan F.X. Ladeira
Yan F.X. Ladeira
DMDiego Martins
Diego Martins
AMAmanda Miranda
Amanda Miranda
AMAdolfo Henrique Moraes
Adolfo Henrique Moraes
(S)-Norcoclaurine synthase ((S)-NCS) catalyzes the stereoselective Pictet-Spengler condensation between dopamine and 4-hydroxyphenylacetaldehyde, forming (S)-norcoclaurine, a central precursor in benzylisoquinoline alkaloid biosynthesis. Beyond its biological role, (S)-NCS is a promising biocatalyst for the sustainable synthesis of chiral tetrahydroisoquinolines, which are valuable scaffolds in medicinal chemistry. However, broader application of this enzyme in biocatalysis remains limited by the lack of simple, selective, non-expensive, and high-throughput methods to quantify its activity. Herein, we describe a straightforward colorimetric method to monitor (S)-NCS activity by selectively detecting dopamine using ninhydrin. Our protocol combines ethanol-induced enzyme precipitation with mild incubation conditions, ensuring reliable, interference-free quantification by standard UV-Vis spectrophotometry. This low-cost, straightforward assay provides a robust alternative to conventional analytical methods. It has the potential to be adapted for high-throughput screening and may serve as a starting point for developing methods to monitor other enzymatic reactions that consume primary amines, facilitating studies in enzyme engineering and sustainable biocatalysis.

29 July 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
DMDiego Martins
Diego Martins
PFPhilipe Oliveira Fernandes
Philipe Oliveira Fernandes
LVLucas Vieira
Lucas Vieira
TBTiago Brandão
Tiago Brandão
AMAdolfo Henrique Moraes
Adolfo Henrique Moraes
Abelson kinase (Abl) is crucial in metabolic pathways, and it is a molecular target for leukemias, especially chronic myeloid leukemia. Despite extensive research on its kinase function and inhibition over the years, there is still considerable room for new discoveries regarding its mechanistic and reactive aspects. We report here, for the first time, the intrinsic ATPase activity of Abl in the absence of peptide substrates. Using quantitative one-dimensional 31 P nuclear magnetic resonance spectroscopy, we monitored the conversion of ATP to ADP and inorganic phosphate (Pi) catalyzed by Abl. Furthermore, we demonstrated that the known kinase inhibitors imatinib and dasatinib inhibit ATPase activity. Beyond expanding the biochemical repertoire of Abl, this finding enables a straightforward, substrate-free assay for kinase inhibition, offering new perspectives on kinase catalytic plasticity and laying the groundwork for simplified screening strategies in drug discovery.

16 June 2026 in Kinases and Phosphatases
Verified
Journal Article
Open access
PDF file
MPMOZART SILVIO PEREIRA
MOZART SILVIO PEREIRA
HAHeveline Oliveira Morais Arruda
Heveline Oliveira Morais Arruda
DMDiego Martins
Diego Martins
PFPhilipe Oliveira Fernandes
Philipe Oliveira Fernandes
ASAdriano Sabino
Adriano Sabino
AMAdolfo Henrique Moraes
Adolfo Henrique Moraes
Janus kinase 2 (JAK2) occupies a central position in cytokine signaling and plays essential roles in hematopoiesis, immune regulation, and cancer. Although recent advances in structural biology, cryo-EM, receptor modeling, and biophysical analysis have substantially expanded current views of JAK2 function, key mechanistic questions remain regarding how receptor geometry, JH2-mediated autoinhibition, and disease-associated mutations are structurally integrated. In this review, we discuss the multidomain organization of JAK2 and examine how the FERM–SH2 module, the pseudokinase domain (JH2), and the catalytic kinase domain (JH1) cooperate to govern receptor specificity, allosteric control, and cytokine-induced activation. We further analyze how pathogenic mutations rewire this regulatory system by weakening autoinhibitory contacts, altering linker-mediated communication, or stabilizing active dimeric conformations. Finally, we assess current and emerging therapeutic strategies, from ATP-competitive inhibitors to macrocyclic and JH2-selective allosteric modulators, with emphasis on how structural insight can guide next-generation drug design. These advances support a more integrated view of JAK2 regulation and define new opportunities for selective therapeutic intervention.